Technical Analysis for SXTP - 60 Degrees Pharmaceuticals, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -5.29% | |
| MACD Bullish Signal Line Cross | Bullish | -5.29% | |
| NR7 | Range Contraction | -5.29% | |
| Inside Day | Range Contraction | -5.29% | |
| 20 DMA Resistance | Bearish | -7.35% | |
| Doji - Bearish? | Reversal | -7.35% | |
| Gapped Up | Strength | -7.35% |
| Alert | Time |
|---|---|
| 2x Volume Pace | about 14 hours ago |
| 3x Volume Pace | about 14 hours ago |
| Outside Day | about 14 hours ago |
| Fell Below Previous Day's Low | about 14 hours ago |
| Reversed from Up | about 14 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/28/2024
60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Infectious Diseases Infection Malaria Covid 19 Dengue Epidemiology Tropical Diseases Vaccine Preventable Diseases Candidiasis Dengue Fever Tick Borne Diseases Treatment Of Infectious Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Infectious Diseases Infection Malaria Covid 19 Dengue Epidemiology Tropical Diseases Vaccine Preventable Diseases Candidiasis Dengue Fever Tick Borne Diseases Treatment Of Infectious Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 8.65 |
| 52 Week Low | 0.2011 |
| Average Volume | 201,473 |
| 200-Day Moving Average | 0.70 |
| 50-Day Moving Average | 0.25 |
| 20-Day Moving Average | 0.23 |
| 10-Day Moving Average | 0.22 |
| Average True Range | 0.02 |
| RSI (14) | 38.65 |
| ADX | 13.33 |
| +DI | 18.20 |
| -DI | 13.59 |
| Chandelier Exit (Long, 3 ATRs) | 0.22 |
| Chandelier Exit (Short, 3 ATRs) | 0.27 |
| Upper Bollinger Bands | 0.26 |
| Lower Bollinger Band | 0.20 |
| Percent B (%b) | 0.21 |
| BandWidth | 24.58 |
| MACD Line | -0.01 |
| MACD Signal Line | -0.01 |
| MACD Histogram | 0.001 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.28 | ||||
| Resistance 3 (R3) | 0.28 | 0.27 | 0.27 | ||
| Resistance 2 (R2) | 0.27 | 0.25 | 0.26 | 0.26 | |
| Resistance 1 (R1) | 0.24 | 0.24 | 0.23 | 0.23 | 0.26 |
| Pivot Point | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 |
| Support 1 (S1) | 0.20 | 0.21 | 0.19 | 0.19 | 0.17 |
| Support 2 (S2) | 0.18 | 0.20 | 0.18 | 0.16 | |
| Support 3 (S3) | 0.15 | 0.18 | 0.16 | ||
| Support 4 (S4) | 0.15 |
